For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
21
views
7
references
 Top references
cited by
26
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
2 collections
    0
    shares
      16
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found

      Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evidence is accumulating that COVID‐19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVID‐19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARS‐CoV‐2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring after COVID‐19 vaccination.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          Cutaneous Reactions Reported after Moderna and Pfizer COVID-19 Vaccination: A Registry-Based Study of 414 Cases

          Devon E McMahon, Erin Amerson, Misha Rosenbach … (2021)
          Background Cutaneous reactions after mRNA-based COVID-19 vaccines have been reported but are not well characterized. Objective To evaluate morphology and timing of cutaneous reactions after mRNA COVID-19 vaccines. Methods A provider-facing registry-based study collected cases of cutaneous manifestations after COVID-19 vaccination. Results From December 2020-February 2021, we recorded 414 cutaneous reactions to mRNA COVID-19 vaccines from Moderna (83%) and Pfizer (17%). Delayed large local reactions were most common, followed by local injection site reactions, urticarial eruptions, and morbilliform eruptions. Forty-three percent of patients with first dose reactions experienced second dose recurrence. Limitations Registry analysis does not measure incidence. Morphologic misclassification is possible. Conclusion We report a spectrum of cutaneous reactions after COVID-19 mRNA vaccines. Most patients with first dose reactions did not develop a second dose reaction, and no patients in the registry developed serious adverse events after the first or second dose. These data provide reassurance to patients and providers.
          Article 0 comments Cited 402 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            COVID-19 vaccines: modes of immune activation and future challenges

            John Teijaro, Donna Farber (2021)
            The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide dissemination across the global population and the inclusion of newly licensed mRNA platforms. We discuss here how the approved vaccines trigger innate immunity to promote durable immunological memory and consider the future implications of protecting populations with these vaccines.
            Article 0 comments Cited 353 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Prompt onset of Rowell's syndrome following the first BNT162b2 SARS‐CoV‐2 vaccination

              T. Gambichler, L. Scholl, H. Dickel … (2021)
              Article 0 comments Cited 29 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                A. Kreuter:
                ORCID: https://orcid.org/0000-0003-2275-499X
                alexander.kreuter@helios-gesundheit.de
                Journal
                Journal ID (nlm-ta): Clin Exp Dermatol
                Journal ID (iso-abbrev): Clin Exp Dermatol
                Journal ID (doi): 10.1111/(ISSN)1365-2230
                Journal ID (publisher-id): CED
                Title: Clinical and Experimental Dermatology
                Publisher: John Wiley and Sons Inc. (Hoboken )
                ISSN (Print): 0307-6938
                ISSN (Electronic): 1365-2230
                Publication date (Electronic): 13 September 2021
                Publication date PMC-release: 13 September 2021
                Electronic Location Identifier: 10.1111/ced.14858
                Affiliations
                [ 1 ] Department of Dermatology, Venereology and Allergology HELIOS St Elisabeth Hospital Oberhausen University Witten/Herdecke Witten Germany
                [ 2 ] Institute of Pathology Mülheim an der Ruhr Germany
                Author information
                https://orcid.org/0000-0003-2275-499X
                Article
                Publisher ID: CED14858
                DOI: 10.1111/ced.14858
                PMC ID: 8444843
                PubMed ID: 34291477
                SO-VID: a0ba42ca-e5b2-48c3-9896-67a5dc10038a
                Copyright © © 2021 British Association of Dermatologists
                License:

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                Date revision received : 19 July 2021
                Date received : 15 July 2021
                Date accepted : 20 July 2021
                Page count
                Figures: 2, Tables: 1, Pages: 3, Words: 2468
                Categories
                Subject: Letter to the Editor
                Subject: Correspondence
                Custom metadata
                source-schema-version-number 2.0
                edited-state corrected-proof
                details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.7 mode:remove_FC converted:16.09.2021

                ScienceOpen disciplines: Dermatology
                Data availability:
                ScienceOpen disciplines: Dermatology

                Comments

                Comment on this article

                scite_

                Similar content16

                See all similar

                Cited by26

                See all cited by

                Most referenced authors68

                See all reference authors